In order to increase the clinical value of Src inhibitors in tumour therapy, more specific inhibitors can be designed through structural biology and conformational relationship studies in the future [540, 541], and efficient combination regimens and other therapeutic strategies can be explored [542]. Here, SRC is linked to neoplasm.